ARCHIVES

June issue of Business & Regulatory Report included.

This article is from The Cancer Letter archive.

Vol. 30 No. 27 | July 2, 2004

Download PDF Visit The Full Archive

Related Articles

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

October 6, 1989

Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat

September 1, 1978

NAS Honors David Kessler; Satcher Seeks Obesity Plan.

January 12, 2001

In Brief: IOM Cancer Policy Forum names six at-large members

August 1, 2014

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998

DCBD Concepts Approved

November 8, 1985